Drug intelligence / Profile preview

Na-ASP-2 + Alhydrogel

Development stage
Discontinued
Lead developer
Baylor College of Medicine
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Na-ASP-2 + Alhydrogel is an investigational recombinant protein subunit vaccine developed by the Baylor College of Medicine for the prevention of hookworm infection caused by *Necator americanus*. The vaccine contains a 21 kDa recombinant protein, Ancylostoma Secreted Protein-2 (ASP-2), which is expressed in the yeast *Pichia pastoris* and adsorbed to the adjuvant Alhydrogel (aluminum hydroxide). Its mechanism of action involves the induction of neutralizing antibodies against the ASP-2 protein, which is secreted by infective larvae; these antibodies are intended to interfere with larval migration and the establishment of infection in the host. Although Phase 1 trials in hookworm-naive adults in the United States were successful, a Phase 1 trial in Brazil was terminated because participants with prior hookworm exposure developed immediate generalized urticarial reactions due to pre-existing IgE antibodies against the Na-ASP-2 antigen.

Other names
Na-ASP-2 Hookworm VaccineNa-ASP2 Hookworm VaccineNa-ASP 2 Hookworm VaccineNecator americanus Ancylostoma Secreted Protein-2 vaccine
02

Targets

ASP-2 (Ancylostoma-secreted protein 2)

Beyond the preview

Go deeper on Na-ASP-2 + Alhydrogel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Na-ASP-2 + Alhydrogel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call